Autres langues Inhalation Sciences Sweden AB

Actions

ISAB

SE0009983893

Equipement et technologie médicale avancés

Cours en clôture SPOTLIGHT STOCK MARKET AB Autres places de cotation 17/07/2026			Varia. 5j.	Varia. 1 janv.
0,2270 ^SEK	+10,19%		+1,79%	-94,77%

16/06	Inhalation Sciences reçoit une subvention de recherche de 0,4 million de couronnes	FW
29/05	Inhalation Sciences poursuit l'examen d'une cession et alerte de nouveau sur son manque de financement	FW

Autres langues

18/05	Inhalation Sciences Sweden Wins Inhalation Research Services Order
18/05	Inhalation Sciences receives IRS order worth approximately EUR 117,000
18/05	Inhalation Sciences Sweden AB Receives IRS Order Worth Approximately EUR 117,000
11/05	Inhalation Sciences Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2026
24/03	Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
24/03	Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
24/03	Inhalation Sciences Sweden AB Secures Additional PreciseInhale Service Orders Worth SEK 350,000
27/02	Inhalation Sciences Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
18/02	Inhalation Sciences Sweden AB Receives New Inhalation Research Services Order for DissolvIt Worth Approximately EUR 139,000
18/02	Inhalation Sciences Sweden Wins DissolvIt System Order
18/02	Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000
27/01	Inhalation Sciences Sweden Wins Inhalation Research Service Orders
27/01	Inhalation Sciences Sweden AB Receives New IRS Orders Worth EUR 52,000 from Global Pharmaceutical Companies
27/01	Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies
27/01	Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies
22/12	Inhalation Sciences Sweden Secures Testing Technology Supply Deal
22/12	Inhalation Sciences receives major IRS order for DissolvIt® from leading global pharma company
22/12	Inhalation Sciences Sweden AB Receives Major IRS Order for DissolvIt®? from Leading Global Pharmaceutical Company
11/12	Inhalation Sciences: Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference
11/12	Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference
04/12	Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market
04/12	Inhalation Sciences Sweden AB Receives Purchase Order Worth EUR 160,000 from International Distributor for the US Market
21/11	Inhalation Sciences Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
04/11	Inhalation Sciences Sweden Hires PharmaVentures to Explore Potential Sale of Operations
04/11	Inhalation Sciences: Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations